DocGo (DCGO) director gets 100,000 RSUs, sells 16,850 shares

Rhea-AI Filing Summary

DocGo Inc. director and officer Ely D. Tendler reported insider equity activity. On December 12, 2025 he was granted 100,000 restricted stock units (RSUs) under DocGo's 2021 Stock Incentive Plan, vesting in four equal annual installments on each of the first four anniversaries of that date, with each RSU delivering one share of common stock upon vesting. Following this grant, he beneficially owned 275,645 securities.

On December 15, 2025 he disposed of 16,850 shares of common stock at $0.91 per share to cover taxes due in connection with the vesting of RSUs on December 12, 2025, which were granted in 2023 and 2024. After this tax-related sale, he beneficially owned 258,795 securities, including earlier RSU awards scheduled to vest in 2026 and 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tendler Ely D

(Last) (First) (Middle)

C/O DOCGO INC.

685 THIRD AVENUE, 9TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		100,000(1)	A	$0	275,645(2)	D
Common Stock	12/15/2025		S		16,850(3)	D	$0.91	258,795(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

2. In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

3. The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs on December 12, 2025. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024.

Remarks:

	/s/ Jerilyn Laskie, as Attorney-in-Fact for Ely D. Tendler	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) report for Ely D. Tendler?

The filing shows that Ely D. Tendler, a DocGo director and officer, received 100,000 restricted stock units (RSUs) on December 12, 2025 and later disposed of 16,850 shares of common stock on December 15, 2025.

How many RSUs were granted to DocGo's General Counsel in this Form 4?

DocGo granted its General Counsel and Secretary, Ely D. Tendler, 100,000 RSUs on December 12, 2025 under the company’s 2021 Stock Incentive Plan.

What is the vesting schedule for Ely D. Tendlers new 100,000 DocGo RSUs?

The 100,000 RSUs granted on December 12, 2025 will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, with each RSU converting into one share of common stock at vesting.

Why did Ely D. Tendler sell 16,850 DocGo (DCGO) shares?

The filing explains that the 16,850-share disposition of common stock at $0.91 per share on December 15, 2025 was made to cover taxes due in connection with the vesting of RSUs on December 12, 2025.

How many DocGo securities does Ely D. Tendler beneficially own after these transactions?

After the December 15, 2025 tax-related share sale, Ely D. Tendler beneficially owned 258,795 securities, which include previously granted RSUs scheduled to vest in 2026 and 2027.

What additional RSU awards for DocGo (DCGO) are disclosed for Ely D. Tendler?

Beyond the new 100,000 RSUs, the filing notes 48,449 RSUs that will vest in two equal annual installments on December 12, 2026 and December 12, 2027, and 17,900 RSUs that will vest on December 12, 2026.